According to recent reports, PTRH2 mutations have been shown to be one of the molecular mechanisms leading to ataxia and cerebellar atrophy in patients with multisystem neurological, endocrine and pancreatic diseases in infancy (Picker-Minh et al., 2022). The gene discussed is PTRH2; the disease is Ataxia.